Sulindac and its derivatives: a novel class of anticancer agents.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Current opinion in investigational drugs

• Publication date

  2001-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 11569947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Cyclodextrins-Digitonin Inclusion Complexes: Synthesis, Characterization, and Thermal Stability for Enhanced Encapsulation Performance

  2026cites this paper
• Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages

  2024cites this paper
• Screening and effect analysis of specific small molecule inhibitors of programmed death moleculesin plant

  2023cites this paper
• Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis

  2023cites this paper
• Macrophages: A rising star in immunotherapy for chronic pancreatitis.

  2022cites this paper
• Sulindac and vitamin D3 synergically inhibit proliferation of MCF‐7 breast cancer cell through AMPK/Akt/β‐catenin axis in vitro

  2021cites this paper
• Identification of drug candidates for breast cancer therapy through scaffold repurposing: A brief review.

  2020cites this paper
• Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review

  2020cites this paper
• PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity.

  2020cites this paper
• Radioprotective Potential of Sulindac Sul fi de to Prevent DNA Damage Due to Ionizing Radiation

  2019cites this paper
• Radioprotective Potential of Sulindac Sulfide to Prevent DNA Damage Due to Ionizing Radiation

  2019cites this paper
• Regioselective and oxidant-free sulfinylation of indoles and pyrroles with sulfinamides.

  2019cites this paper
• The Guanylate Cyclase C—cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia

  2018cites this paper
• Clinical Research and Practice

  2017cites this paper
• Tri- and diorganotin(IV) derivatives of non-steroidal anti-inflammatory drug sulindac: Characterization, electronic structures (DFT), DNA binding and plasmid cleavage studies

  2017cites this paper
• The effect of pentoxifylline on L-1 sarcoma tumor growth and angiogenesis in Balb/c mice

  2017cites this paper
• Synergistic Activity for Natural and Synthetic Inhibitors of Angiogenesis Induced by Murine Sarcoma L-1 and Human Kidney Cancer Cells.

  2017cites this paper
• Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.

  2016cites this paper
• Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator

  2016cites this paper
• Thermal characterization of some polymorph solvates of the anti-inflammatory/anti-cancer sulindac

  2016cites this paper
• The Evolving Role of Nonsteroidal Anti-Inflammatory Drugs in Colon Cancer Prevention: A Cause for Optimism

  2015cites this paper
• JPET #220806 1 The evolving role of NSAIDs in colon cancer prevention: A cause for optimism

  2015cites this paper
• NSAIDs and Colorectal Cancer Control: Promise and Challenges

  2015cites this paper
• Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation.

  2013cites this paper
• cGMP-Dependent Protein Kinase Iβ Interacts with p44/WDR77 to Regulate Androgen Receptor-Driven Gene Expression

  2013cites this paper
• Aspirin effects on the activation of c-Src-induced NF-κB-dependent apoptotic mechanisms in colorectal cancer

  2013cites this paper
• Chitosan/cyclodextrin nanoparticles as drug delivery system

  2012cites this paper
• Ras inhibition via direct Ras binding--is there a path forward?

  2012cites this paper
• The novel compound OSI-461 induces apoptosis and growth arrest in human acute myeloid leukemia cells

  2012cites this paper
• Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents

  2012cites this paper
• Phospho-Sulindac (OXT-328) Inhibits the Growth of Human Lung Cancer Xenografts in Mice: Enhanced Efficacy and Mitochondria Targeting by its Formulation in Solid Lipid Nanoparticles

  2012cites this paper
• Praziquantel Synergistically Enhances Paclitaxel Efficacy to Inhibit Cancer Cell Growth

  2012cites this paper
• The effect of sulindac, a non-steroidal anti-inflammatory drug, attenuates inflammation and fibrosis in a mouse model of chronic pancreatitis

  2012cites this paper
• Sulindac Sulfide – Induced Stimulation of Eryptosis

  2012cites this paper
• Cyclic 3′,5′‐guanosine monophosphate‐dependent protein kinase inhibits colon cancer cell adaptation to hypoxia

  2011cites this paper
• PKG inhibits TCF signaling in colon cancer cells by blocking β-catenin expression and activating FOXO4

  2010cites this paper
• Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations

  2010cites this paper
• cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment.

  2010cites this paper
• NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.

  2010cites this paper
• Current concepts in colorectal cancer prevention

  2009cites this paper
• Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress

  2009cites this paper
• The Prostate 69 : 610 ^ 623 ( 2009 ) Piperazine-Designed a 1 A / a 1 D-AdrenoceptorBlocker KMUP-1 andDoxazosin ProvideDown-Regulationof AndrogenReceptor andPSAin Prostatic LNCaPCells Growthand Specifically inXenografts

  2009cites this paper
• Expression of cyclic guanosine monophosphate‐dependent protein kinase in metastatic colon carcinoma cells blocks tumor angiogenesis

  2008influential citation
• Principe des mécanismes d'action des thérapeutiques moléculaires ciblées en cancérologie pulmonaire

  2008cites this paper
• Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations

  2008cites this paper
• Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells.

  2007cites this paper
• A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells.

  2006cites this paper
• The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization

  2006cites this paper
• Arrest of Cancer Cells Induced Apoptosis and Growth − Anti-inflammatory Drug Associated Gene-7 / Interleukin-24 Mediates Nonsteroidal A Novel Pathway Involving Melanoma Differentiation

  2006cites this paper
• A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501)

  2006cites this paper
• An anti-tumor role for cGMP-dependent protein kinase.

  2006cites this paper
• Cyclooxygenase-2 (COX-2) overexpression in childhood brain tumors.

  2006cites this paper
• Session 5: Functional Proteomics I

  2004cites this paper
• Molecular biological design of novel antineoplastic therapies

  2004cites this paper
• Select Cyclic Nucleotide Phosphodiesterase Inhibitors in Colon Tumor Chemoprevention and Chemotherapy

  2004cites this paper
• Cyclic GMP-Dependent Protein Kinase: Targeting and Control of Expression

  2003cites this paper
• Anti-Angiogenic and Apoptotic Effects of Metabolites of Sulindac on Chick Embryo Chorioallantoic Membrane

  2003cites this paper
• Hormone-refractory prostate cancer: new horizons.

  2003cites this paper
• CHAPTER 200 – Cyclic GMP-Dependent Protein Kinase

  2003cites this paper
• Protein Kinases in the Regulation of Apoptosis in B-cell Chronic Lymphocytic Leukemia

  2003cites this paper
• Prostate cancer update

  2002cites this paper
• Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents.

  2002cites this paper
• Meloxicam inhibits the growth of non-small cell lung cancer.

  2000cites this paper